Emerald Health Therapeutics Inc EMHTF

RE:RE:What a bunch of fraud BS

[rrrrrrrrrrrr]

Look up Martin Broadwell and the definition of unconsciously incompetent. A little self-reflection could be healthy.

It is rare that any supply agreement is set to be punitive on a customer (buyer) in the long term. The issue missed by EMH (and most of the market) is the speed of commoditization and will impact EMH in 2019. It will also impact VFF, EMH, PSF and the rest of the market in the short/medium term. VFF will confirm the facts around the supply agreement past 2019 so just call them.  There is no material ongoing exposure to EMH past 2019.
 
VFF has no death grip on EMH. The only contractual relationship between VFF and EMH is around the default on the Delta 2 payment(s).  The shareholder agreement contemplates this and allows for that event.  In this case it would not be a major issue and would represent around 6% total dilution (based on a $250M PSF valuation) in PSF if all outstanding payments are not made by EMH and the full $7.55M is funded by VFF. A long way from a death grip.
 
The cure period for the Dec 2 payment is 10 business days so we will know by Monday or Tuesday what EMH is going to do. If they do not make the payment, that looks like a reasonable cash management strategy. If they do make the payment then either they are just strengthen their negotiation position with VFF/PSF on the outstanding issues OR they have more flexibility on cash then the market thought.